Target intelligence / Profile preview

Lysine methyltransferase 2C pseudogene 2 (KMT2CP2)

Target
KMT2CP2
Molecular classification
Other (Pseudogene)
01

Overview

KMT2CP2, or Lysine methyltransferase 2C pseudogene 2, is a non-functional DNA sequence classified as a pseudogene. It resembles the functional gene KMT2C, which encodes the histone methyltransferase enzyme MLL3. Pseudogenes like KMT2CP2 are not translated into functional proteins and are not targets for pharmacological intervention. Distinct from the functional KMT2C gene, KMT2CP2 has no established role in epigenetic regulation, development, or disease. All molecular functions, disease associations, and drug interactions listed for KMT2C/MLL3 do not apply to KMT2CP2[1][3][4][5][7].\n\nKMT2CP2 is a nucleic acid sequence deemed non-functional and not a pharmacological or research target. References to biological activities, molecular function, disease involvement, or drug targeting exclusively relate to KMT2C/MLL3, the functional gene/protein, and should not be attributed to the pseudogene KMT2CP2[1][3][4][5][7].

02

Mechanism of action

None (as no drugs interact with this pseudogene)

03

Biological functions

None; it does not have known biological function as a protein or enzyme, as it is classified as a pseudogene
04

Disease associations

None (no confirmed direct disease role for the pseudogene variant; roles described in literature pertain to the functional gene KMT2C/MLL3)
05

Safety considerations

None (no therapeutic activity inferred)
06

Interacting drugs

None (there are no drugs targeting pseudogenes, including KMT2CP2)
07

Biomarkers

None established (biomarkers are described for active KMT2C/MLL3, not KMT2CP2)

Beyond the preview

Go deeper on Lysine methyltransferase 2C pseudogene 2 (KMT2CP2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lysine methyltransferase 2C pseudogene 2 (KMT2CP2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call